Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Management: Artificial Intelligence in Clinical Practice.
Innov Clin Neurosci
December 2024
Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS).
This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by PRMS (www.
View Article and Find Full Text PDFSelf-efficacy scale for university teaching in virtual environments, SSUTVE.
Heliyon
January 2025
Instituto de Investigación FCCTP, Facultad de Ciencias de la Comunicación, Turismo y Psicología, Universidad de San Martín de Porres, Lima, Peru.
Self-efficacy is relevant in explaining performance and well-being in different domains of human behaviour. Despite this need, there are no instruments that assess self-efficacy in university teaching in virtual environments. Therefore, the objective of this study was to design the Self-Efficacy Scale for University Teaching in Virtual Environments (SSUTVE) and analyse its psychometric properties.
View Article and Find Full Text PDFIs It All in Your Head? Placebo Effects in Concussion Prevention.
Sports Med
January 2025
School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia.
Sports-related concussions (SRCs) are a major health issue in athletes of varying ages, ability levels, and sports. Concerns over the short- and long-term consequences of SRCs have incentivized a wealth of products and policies aimed at reducing SRC risk. Research suggesting the effectiveness of such interventions at reducing SRCs has facilitated their adoption by sports organizations and, in some cases, product commercialization.
View Article and Find Full Text PDFCurrent Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA.
Clin Pharmacol Ther
January 2025
European Medicines Agency, Amsterdam, The Netherlands.
Physiologically Based Pharmacokinetic (PBPK) Models are routinely used in drug development and therefore appear frequently in marketing authorization applications (MAAs) to the European Medicines Agency (EMA). For a model to be a key source of evidence for a regulatory decision, it must be considered qualified for the intended use. Advice on the data expected to allow qualification of a PBPK model or platform is provided in the EMA Guideline on the reporting of PBPK modeling and simulation.
View Article and Find Full Text PDFResponse to the letter from members of the ICBE-EMF.
Environ Int
December 2024
Department of Oncology and Molecular Medicine, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy(2).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!